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CLINICAL INVESTIGATION
A clinicopathologic study of forty-eight infants with
nephrotic syndrome
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A clinicopathologic study of forty-eight infants with nephrotic syn-
drome. The clinical and histopathologic features of 48 children present-
ing with the nephrotic syndrome during the first year of life were
analyzed. Proteinuria was discovered soon after birth to 3 months of
age in 39 infants (congenital nephrotic syndrome), and nine infants had
an infantile onset presenting between 4 and 12 months of age. Neither
histologic parameters—microglomeruli, epithelial, or mesangial prolif-
eration, focal segmental or global sclerosis, fibrinoid necrosis, or
tubular microcysts—nor histologic classification—microcystic disease,
mesangial proliferative glomerulonephritis, focal segmental glomerular
sclerosis/hyalinosis—predicted the outcome. Rather, age at presentation
was found to predict outcome: One of 39 infants with a congenital onset
and seven of nine infants with an infantile onset underwent a complete
remission (P < 0.0001).
Une étude anatomo-clinique de quarante-huit nourrissons avec syn-
drome néphrotique. Les caractéristiques cliniques et histopathologiques
de 48 enfants atteints de syndrome néphrotique au cours de la premiere
année de vie ont été analysées. La protéinurie avait ete decouverte peu
aprés Ia naissance, jusqu'à l'flge de 3 mois chez 39 nourrissons
(syndrome nephrotique congenital) et neuf nourrissons avaient eu un
debut infantile, entre les ages de 4 et 12 mois. Ni les paramétres
histologiques—microglomérules, proliferation épithéliale ou mésan-
giale, scierose segmentaire et locale ou globale, nécrose fibrinoide ou
microkystes tubulaires—ni la classification histologique—maladie
microkystique, glomerulonéphnte proliferative mésangiale, sclérose/
hyalinose glomCrulaire segmentaire et focale n'etaient prédictifs du
devenir. A l'opposé, l'flge a Ia découverte était prédictif du devenir:
L'un des 39 nourrissons ayant un debut congenital et sept des neuf
nourrissons ayant un debut infantile ont eu une remission complete (P
<0,0001).
The majority of patients who present with the nephrotic
syndrome during the first year of life have been classified as
either the congenital nephrotic syndrome of the "Finnish" type
or infantile microcystic disease [1—17], or infrequently as diffuse
mesangial sclerosis [7, 10, 13, 17—20], minimal change nephrotic
syndrome [7, 11, 13, 17], and focal segmental glomerular-
sclerosis and hyalinosis [3, 7, 21]. Rare causes of the nephrotic
syndrome during the first year of life include Wilms' tumor [221,
nail-patella syndrome [23,1, pseudohermaphroditism [24], XY
gonadal dysgenesis [251, mercury intoxication [26], the hemo-
lytic-uremic syndrome, syphilis [15], and toxoplasma infection
[27]. Habib and Bois [71, Kaplan, Bureau, and Drummond [11],
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and George, Hickman, and Striker [5] have suggested that the
histologic features present in renal biopsy specimens can be
utilized in the recognition of these clinical pathologic entities,
and may be important in predicting differences in response to
treatment, genetic counselling, and ultimate prognosis.
To examine this postulate, we studied 48 infants presenting
with the nephrotic syndrome during the first year of life. The
clinical features, response to various therapeutic regimens, and
results of renal transplantation in 39 of these infants are
presented elsewhere in detail [28]. Here we examine the his-
tologic features present in the 48 infants and correlate these
features with the clinical outcome.
Methods
Patients. The records of all children presenting with the
nephrotic syndrome before 1 year of age between 1954 and
August 1982 at the University of Minnesota were reviewed.
Kidney tissue samples from 48 children studied by biopsy (45
diagnostic and 10 follow-up biopsy specimens) and/or nephrec-
tomy (20 patients), and autopsy (1 patient) were identified and
form the basis of this report. Thirty-nine of the patients had
proteinuria and edema between 0 and 3 months of age and were
clinically classified as having the congenital nephrotic syn-
drome. Their clinical and laboratory features, medical manage-
ment, and results of renal transplantation have been reported in
detail [28]. Some of these patients have also been described
previously [10, 26]. Nine patients in whom signs and symptoms
of nephrotic syndrome developed between 4 and 12 months of
age were considered to have the infantile nephrotic syndrome.
All statistical analyses were performed utilizing the Fisher
exact test. The P value was considered significant if less than
0.01.
Light microscopy. Biopsies performed at the University of
Minnesota prior to July 1976 were fixed in 10% buffered
formaldahyde. Since then, tissues were fixed in Zencker's fluid,
with serial sections cut at 2-jzm thickness and stained with
PAS-alcian blue and hematoxylin and eosin. The original slides
were reviewed, sections re-cut, and stained if the patients were
seen prior to 1976. The glass slides from several referral
patients were obtained and reviewed. The patients were cat-
egorized according to conventional histologic criteria. All pa-
tients with tubular microcysts as described by Hailman, Norio,
and Rapola [8] were classified as Finnish microcystic disease
(Fig. 1). Biopsy specimens without microcysts were classified
as focal segmental glomerular sclerosis and hyalinosis (Fig. 2)
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Fig. 1. Finnish microcystic disease—a 3-month old male of Swedish
ancestry with a history of edema since 1 month of age. The biopsy
specimen revealed extensive tubular microcysts, prominent mesangial
proliferation, and a few microglomeruli. He is presently alive and well
5 years after reral transplantation. (H&E, >< 64)
when segmental sclerotic areas with or without mesangial
proliferation were evident, as mesangial proliferative glomeru-
lonephritis (Fig. 3) when mesangial proliferation without seg-
mental sclerosis was evident, as minimal change nephrotic
syndrome (Fig. 4) when there was no lesion evident by light
microscopy, and as diffuse mesangial sclerosis (Fig. 5) when
small glomeruli with shrunken tufts and mesangial sclerosis
were evident as described by Habib and Bois [71.
Electron microscopy. Tissue samples from 22 of the patients,
16 with a congenital onset and 6 with an infantile onset, were
studied with the electron microscope. The tissues for
ultrastructural examination were embedded in a variety of
plastic substances prior to July 1976 after which all samples
were embedded in epon plastic. Primary fixation occurred in
2.5% glutaraldahyde with Millonig's phosphate buffer, postfix-
tion in 1.5% osmium tetroxide, and dehydration in graded
ethanols. Glomeruli were selected from l-tm thick toluidine
blue-stained sections. Thin sections were stained with lead
citrate and uranyl acetate and examined in a transmission
electron microscope (Phillips 201, Phillips Research Laborato-
ries, Eindhoven, The Netherlands). Many of the patients were
referred to the tJniversity of Minnesota for possible renal
transplantation, and glass slides, paraffin blocks and plastic-
embedded tissue samples for ultrastructural examination, or
Fig. 2. Focal segmental glomerulosclerosis and hyalinosis—a 2-mont h-
old female with a history of edema since birth. A biopsy specimen
revealed mild focal segmental mesangial proliferation and two glomeruli
with segmental sclerosis. There were no tubular microcysts. She is
presently alive and well 7 3/4 years after renal transplantation. (PAS,
x 570)
electron photomicrographs were obtained from the referring
institutions and reviewed.
Immunofluorescent microscopy. Immunofluorescent micros-
copy was performed on the initial biopsy or nephrectomy
specimen from 14 infants with the onset of nephrotic syndrome
prior to 3 months and in five biopsy specimens from infants with
the onset after 3 months of age. Repeat late biopsy or nephrec-
tomy specimens from three patients with congenital onset were
also examined. Frozen sections from all specimens were
stained with fluorescence-labelled antibodies to human IgG,
1gM, IgA, C3, C4, fibrinogen/fibrin, and properdin as previously
described [291. The fluorescence was graded 0 to 2+ on the
basis of intensity.
Results
Clinical features (Table 1)
Congenital nephrotic syndrome. Edema and/or proteinuria
were evident by 3 months of age in 39 of the infants. Twenty
were female and 19 were male. The average age at presentation
was 4 weeks (range, 0 to 12). Sixteen (41%) had a positive
family history for a similar disease and 9 (23%) were of Finnish
extraction. All of the patients exhibited failure to thrive. Only
nine (23%) of the infants were premature, and placentomegaly
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Fig. 3. Diffuse mesangial proliferative glomerulonephritis—a 7-week-
old female of Swedish-Dutch ancestry with a history of edema since 3
weeks ofage. The biopsy specimen revealed prominent diffuse mesan-
gial proliferation without other lesions. She died at 11 months of age
because of failure to thrive. (H&E, x 220)
was noted in but four. Sixty-three serious bacterial infections
occurred in 35 of the patients (meningitis, 2; sepsis, 13; pneu-
monia, 25; peritonitis, 14; and urinary tract infection, 9). Five
patients underwent pyloroplasty because of pylonc stenosis,
and three additional patients had severe gastroesophogeal
reflux and/or aspiration pneumonia, Treatment of 17 patients
with corticosteroids with or without the addition of cyclophos-
phamide or azathioprine was not beneficial in any patient. One
of the patients had spontaneous remission. Seventeen patients
underwent renal transplantation; 14 of these children are pres-
ently alive and well. Two died in the immediate post-transplant
period and one died of disseminated varicella infection 10 years
post-transplantation with a functioning graft. Three patients
await transplantation. The remaining 18 patients died of
nephrosis complications.
Infantile nephrotic syndrome. Nine patients (one female,
eight males) presented with proteinuria between 5 and 11
months of age (average, 7.8). One patient (11%) had a positive
family history. None were of Finnish extraction. Six of the
patients were treated with prednisone and two with both ACTH
and prednisone. Seven had a complete response to treatment
and are now 3 to 20 years old (average, 10.4 years). There was
no response to steroid treatment in one patient who died at 19
months of age of sepsis 8 months after presentation. None of
Fig. 4. Minimal change nephrotic syndrome—a 10-month-old male
presented with a history of recent onset of edema. Treatment with
prednisone resulted in a complete remission. He is presently 8 years
old. (H&E, x 240)
the other patients had severe bacterial infectious complications.
The ninth patient presented at 8 months of age with severe renal
failure as well as the nephrotic syndrome and died when he was
10 months old of chronic renal failure.
Pathologic features — total series — 48 patients (Table 2)
The patients were first analyzed according to early versus late
biopsy specimens. Tissue samples from 26 patients were ob-
tained before the age of 4.5 months (average, 2.3 months; range,
7 days to 4.4 months) presenting before age 3 months while in 22
patients renal biopsy was performed after 4.5 months of age.
The remaining 13 patients presenting with a congenital onset
underwent biopsy later in the course of their disorder (average,
26.1 months; range, 5.3 to 63 months). Nine presented after the
age of 4 months and biopsy specimens were obtained between
6.25 and 18 months (average, 10.1 months) of age.
Microglomeruli were found more frequently in tissue samples
from younger patients (81% vs. 36%) (P < 0.001). There was no
statistical difference in the frequency of mesangial proliferation
(89% vs. 68%) between the two groups although the degree of
proliferation decreased or even disappeared in late repeat
biopsies or nephrectomies obtained in 14 of the patients. While
30 (63%) of the children eventually had segmental sclerosis and
hyalinosis, 9 (18%) had this feature in early specimens (P <
0.001). Similarly, focal global glomerular sclerosis, while pres-
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increase in 18 patients. In one patient there was mild diffuse
matrix increase and capillary collapse at the expense of mesan-
gial proliferation with obliteration of the entire tuft by the
sclerotic process. Capillary walls were difficult to discern.
Bowman's capsule appeared dilated because of the collapsed
nature of the tufts. These glomeruli had the appearance of
diffuse mesangial sclerosis as described by Habib and Bois [71.
In the remaining 47 patients, the capillary walls were uniformly
thin and usually of normal contour. The capillary loops were
widely patent unless the glomeruli showed areas of segmental
or global sclerosis. Capillary double contours and subepithelial
spikes were not found in any case.
Extracapillary proliferation was evident in 27 patients (17
initial specimens and 10 repeat biopsies or nephrectomies) with
I to 30% of the glomeruli showing segmental (rarely circumfer-
ential) epithelial or fibroepithelial crescents. Segmental
fibrinoid necrosis was evident in the biopsy specimens of four
children; from 1 to 10% of the glomeruli were involved. The
necrosis was usually associated with an adjacent epithelial
crescent. Fibrinoid necrosis of glomeruli and arterials also was
found in nephrectomies of two children with severe hyper-
tension.
Histologic classification (Table3)
Fig. 5. Diffuse mesangial sclerosis—an 8-month-old male presented
with the nephrotic syndrome and renal failure. The glomerular tufts
were shrunken, capillary loops were difficult to discern, and the
mesangium appears widened. He expired of renal failure at age 10
months. (H&E, x400)
ent in 23% of the early biopsy specimens occurred in 55% of the
later biopsy specimens. There was no statistical difference in
the frequency of microcysts between the early and late biopsy
groups (58% vs. 50%).
There was no distinctive light microscopic feature (Table 2),
although combinations of several glomerular and tubular lesions
were seen in a majority of patients. Microglomeruli measuring
from 20 to 40 jm in diameter were found in 29 patients and
involved from 1 to 35% of the glomeruli. In 24 patients 10% or
fewer of the glomeruli were small. Microglomeruli were evident
primarily in tissues obtained early in life but were seen as late as
20 months in one patient.
Mesangial cell proliferation of mild to moderate degree oc-
cuned in 38 infants (79%). These proliferative lesions were
focal and segmental or generalized and diffuse or segmental and
varied in degree from three or fewer cells per mesangial zone( 'hypercellularity") to prominent proliferation in the same
patient. Four patients had entirely normocellular glomeruli and
six had segmental mesangial hypercellularity only. Repeat
biopsy, subsequent nephrectomy, or necropsy specimens in 24
patients did not reveal significant change in the intensity of the
proliferation in ten patients, while in 14 the proliferative lesions
decreased or even disappeared. Silver and/or PAS-alcian blue•
stained sections revealed mild segmental mesangial matrix
Based on initial kidney tissue samples examined, the conven-
tional pathological diagnosis was compared with regard to age
of onset and the eventual occurrence of remission. The patients
were grouped into the following categories: Finnish microcystic
disease (26 patients; Fig. 1), focal segmental glomerular sclero-
sis and hyalinosis (9 patients; Fig. 2), mesangial proliferative
glomerulonephritis (11 patients; Fig. 3), minimal change ne-
phrotic syndrome (1 patient; Fig. 4), and diffuse mesangial
sclerosis (1 patient; Fig. 5). Twenty-two of 26 patients with the
histologic lesion of Finnish microcystic disease had their onset
before 3 months of age and only one patient has a remission. In
contrast, three of the four infants in this diagnostic category,
whose disease began after 3 months of age achieved a complete
remission. Other associated glomerular lesions were common
within this diagnostic category and included microglomeruli
(73%), mesangial proliferation (73%), epithelial crescents
(42%), focal segmental glomeruloscierosis and hyalinosis
(35%), and focal global glomerular sclerosis (42%). None of
these associated lesions occurring with the microcystic disease
were predictive of the eventual remission achieved by the four
patients in this pathologic category.
The pathologic change in nine infants was best categorized as
focal segmental glomerulosclerosis/hyalinosis and included
seven who were less than 3 months of age at the onset of the
disease. Remission occurred in none of these younger infants.
In contrast, complete remission occurred in both infants with
onset after 3 months of age including one in whom 20% of the
glomeruli showed focal segmental glomerulosclerosis/
hyalinosis. The commonly associated lesions in this category
included mesangial proliferation (89%), epithelial cresents
(67%), and focal global sclerosis (56%), none of which predicted
the outcome.
Ten of the 11 infants in the category mesangial proliferative
glomerulonephritis were less than 3 months of age at onset and
none of these infants achieved remission. The other infant with
onset at 7 months eventually had a complete remission. The
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Table 1. Clinical features: congenital and infantile nephrotic syndrome
Type
No. of
cases
Sex
(F/M)
Family
historya Prematurity
Placento-
megaly
Failure to
thrive
Bacterial
infections Remissio&'
Renal
transplantation Death
Congenital
nephrotic
syndrome
39 20/19 16 (41%) 9 (23%) 4 (10%) 39 (100%) 35 (90%) 1 (2.6%) 17 (43.6%) (21) 53.8%
Infantile
nephrotic
syndrome
9 1/8 1(11%) 0 0 0 1(11%) 7(77.8%) 0 2(22.2%)
Total 48 21/27 17 (35%) 9 (19%) 4 (8%) 39 (81%) 36 (92%) 8 (17%) 17 (35%) 23 (48%)
a Positive family history for similar disease in a sibling or near relative.
b Remission is defined as the loss of abnormal proteinuria.
most common associated lesion in this category, microglo-
meruli (73%), did not predict the eventual outcome.
The one patient categorized as minimal change nephrotic
syndrome presented at 10.5 months of age and had a complete
remission following steroid therapy. Focal global glomerular
sclerosis (3%) was the only associated lesion in this patient.
Diffuse mesangial sclerosis characterized the pathology of
one patient. He presented at 8 months and died of renal failure
at 10 months of age.
Electron microscopy
Ultrastructure study was carried out in 16 patients presenting
with the congenital nephrotic syndrome. Nine had microcystic
disease, two had focal segmental glomerularsclerosis and
hyalinosis and five had diffuse mesangial proliferative glomeru-
lonephritis. Electron microscopy was performed in six patients
presenting after the age of 3 months; two had microcystic
disease, two had focal segmental glomerulosclerosis and
hyalinosis, one had minimal change nephrotic syndrome and
one had diffuse mesangial sclerosis.
There was nearly complete epithelial foot process oblitera-
tion in 21 of the 22 patients. Only 70% of the foot processes
were obliterated in a patient with an infantile onset who
eventually underwent a complete remission. Microvillus prolif-
eration of epithelial cell surfaces was seen in all patients and
varied from minimal to marked. In 18 patients the glomerular
basement membranes were thin but of normal thickness for the
patient's age [301 and measured between 110 and 170 nm in
thickness. The basement membranes of two patients with a
congenital onset were thinner than normal measuring 100 nm.
In the endstage kidney of yet another patient the glomerular
basement membranes were thickened to about 300 nm. Finely
granular electron dense deposits localized to the mesangium
were found in the one patient with minimal change nephrotic
syndrome. Only six biopsy specimens showed a mild increase
in mesangial matrix material. One patient had segmental de-
tachment of the epithelium from the capillary wall adjacent to a
collapsed capillary loop. The patient with diffuse mesangial
sclerosis had thickened capillary walls with a prominent basket
weave appearance of the lamina densa, extensive capillary wall
collapse, mild mesangial matrix increase, and mild endothelial-
mesangial cell increase.
Table 2. Frequency of histology features—all patients
Initial
tissue
With additional
tissuea
% %
Microglomeruli 60 60
Mesangial proliferation 79 79
Mesangial hypercellularity 13 13
Extracapillary proliferation 35 56
Fibrinoid necrosis 8 13
Mesangial matrix increase 38 38
Focal segmental
glomerulosclerosis/hyalinosis 38 63
Focal global glomerulosclerosis 38 67
Tubular microcysts 54 63
a The tissue samples were from additional biopsy, nephrectomy, or
autopsy specimens.
Immunofluorescence microscopy
Immunofluorescent microscopy of the initial specimens were
negative in seven patients with a congenital onset although
mesangial staining for IgG, 1gM, and C3 was trace to 2+ in
partially sclerotic glomeruli of each infant. Repeat biopsy or
nephrectomy specimens from three infants whose initial biopsy
specimens were negative showed similar mesangial fluores-
cence in sclerotic glomeruli of these later specimens.
The immunofluorescent microscopy from infants with an
infantile onset was negative in two and demonstrated mesangial
1gM and C3 staining in the other three patients. Prominent
capillary loop staining was not observed in the tissue samples
from either group.
Clinical pathological correlation —family history (Tables 4
and 5)
Seventeen of the children had a positive family history and 31
had negative family histories for a similar disease as shown in
Table 4. There was no statistical difference in the frequency of
any histologic lesion, or histologic diagnosis (Table 5), with
positive or negative family history of nephrotic syndrome in the
first year of life.
Histologic features among siblings (Table 6)
Renal tissue samples from five pairs of siblings, each with a
congenital presentation was examined. The eleven biopsy spec-
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Table 3. Histologic diagnosis, remission, and age at presentation
Number of
Age at presentation patients Remission Total remission
Finnish microcystic disease 0 < 3 months old 22
> 3 months old 4
1 (5%)
3 (75%)
(15%)
Focal segmental glomerulosclerosis 0 < 3 months old 7
> 3 months old 2
0 (0%)
2 (100%)
(22%)
Mesangial proliferative glomerulonephritis 0 < 3 months old 10
> 3 months old 1
0 (0%)
1(100%)
(9%)
Minimal change nephrotic syndrome 0 < 3 months old 0
> 3 months old 1
0 —
1 (100%)
(100%)
Diffuse mesangial sclerosis 0 < 3 months old 0
> 3 months old 1
0 —
0 (0%)
(0%)
Abbreviation: Pts, patients.
Table 4. Histologic features: positive versus negative family history
MG MP MH Normal EP FN
% % % %
FSGS/H
%
FGGS
%
FMC
%
Positive family history (17 Pts) 47 71 18 12 47 6 59 41 65
Negative family history (31 Pts) 68 84 10 6 61 10 26 35 61
P valuea NS NS NS NS NS NS NS NS NS
Abbreviations: MG, microglomeruli; MP, mesangial proliferation; MH, mesangial hypercellularity; normal, normal glomeruli and tubules; EP,
epithelial proliferation; FN, fibrinoid necrosis; FSGS/H, focal segmental glomeruloscierosis/hyalinosis; FGGS, focal global glomerular sclerosis;
FMC, finnish microcystic tubules; Pts, patients.
a P values were achieved with the Fisher exact test.
Table 5. Histologic diagnosis: positive versus negative family history
FMC
%
FSGS/H
%
MesPGN
%
MCNS
%
DMS
%
Positive family
history
(17 Pts) 53 29 18 0 0
Negative family
history
(31 Pts) 55 13 26 3 3
P value NS NS NS NS NS
Abbreviations: FMC, Finnish microcystic disease; FSGS/H, focal
segmental glomerulosclerosis/hyalinosis; MesPGN, mesangial prolif-
erative glomerulonephritis; MCNS, minimal change nephrotic syn-
drome; DMS, diffuse mesangial sclerosis; Pts, patients.
a p values were achieved with the Fisher exact test.
imens, two nephrectomies, and one necropsy renal specimen
obtained between 1 week and 55.5 months of age showed
similarities in histologic features in the tissue samples of each
pair except that only one sibling of each pair had tubular
microcysts. Because of the disparity in microcyst involvement,
the final histologic diagnosis was discordant in all five pairs of
siblings.
Histologic features — clinical course (Table 7)
Eight of the patients underwent remission while 40 patients
had unremitting nephrotic syndrome, died of its complications,
developed chronic renal failure, or underwent renal transplanta-
tion. Comparison of the histologic parameters between the eight
who achieved remission and the 40 who did not revealed no
statistical difference in the frequency of histologic parameters
studied. Because no histologic feature predicted the clinical
outcome, we examined age at presentation and remission rate.
Only one of the 39 (3%) patients presenting with nephrotic
syndrome before 3 months of age underwent a remission while
seven of nine (78%) patients presenting after age 3 months
underwent remission (P < 0.0001). The one infant with a
positive family history who had a remission presented with the
nephrotic syndrome at an age greater than 4 months as did six
of seven infants with a negative family who had a remission.
Thus, remission was associated with the age of the onset of the
disease, but was not related to frequency of any single his-
tologic parameter or the family history.
Discussion
This evaluation of the renal pathology of 48 patients with an
onset of nephrotic syndrome in the first year of life demon-
strates that age at presentation is the primary predictor of the
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Table 6. Comparison of histologic features in siblings
Family
Tissue
studied Age
FSGS/H
%
FGGS
%
MG
%
MP
%
EP
% MC
Histologic
diagnosis
1 a B 28 mo 37.5 0 0 FS1—2+ 0 0 FSGS/H
N 92.5 mo 20 80 0 GD1—2+ 1 0 FSGS/H
b B 20.5 mo 2 75 0 GD2+ 0 0 FSGS/H
N 52mo 1 95 0 FSI—2+ 1 + FMC
2 a B I mo 0 0 25 GD-S 1-2+ 0 + FMC
b B 1 wk 0 0 20 FSI—2+ 0 0 MesPGN
3 a B 1.5 mo 0 0 0 FS2+ 0 0 MesPGN
A 2lmo 5 0 0 0 0 + FMC
b B 1.5 mo 0 0 0 FS2+ 0 0 MesPGN
4a B 27mo 10 1 0 GD+ 0 + FMC
B 50 mo 50 2 0 0 0 0 FSGS/H
b B 3.5 mo 1 1 1 GD-Sl—2+ 3 0 MesPGN
5 a B 55 mo 33 0 0 FS + 0 0 FSGS/H
b B 39 mo 33 0 0 FS2+ 0 + FMC
Abbreviations: age, age when biopsy studied; FSGS/H, focal segmental glomeruloscierosis/hyalinosis; FSGS, focal global glomeruloscierosis;
MG, microglomeruli; MP, mesangial proliferation; EP, epithelial proliferation; MC, tubular microcysts; FMC, Finnish microcystic disease; B,
biopsy; N, nephrectomy; A, autopsy; 0, not present; +, present; MesPGN, mesangial proliferative glomerulonephritis; FS, focal segmental; GS,
generalized diffuse; 1—4+, intensity.
Table 7. Histologic features—clinical course
MG
%
MP
%
MH
%
Normal
%
EP
%
FN
%
FSGS/H
%
FGGS
%
MC
%
Remission (8 Pts) 50 75 0 25 37.5 13 25 50 50
No remission (40 Pts) 62.5 80 15 5 35 8 40 35 55
P value NS NS NS NS NS NS NS NS NS
Abbreviations: MG, microglomeruli; MP, mesangial proliferation; MH, mesangial hypercellularity; EP, epithelial proliferation; FN, fibrinoid
necrosis; FSGS/H, focal segmental glomerulosclerosis/hyalinosis; FGGS, focal global glomerulosclerosis; MC, tubular microcysts.
ultimate outcome of the disease and that the various pathologic
lesions observed were of little value in the assessment of the
nature of the process or its natural history. Our analysis shows
that regardless of the pathologic findings only 3% (one of 39) of
the patients with onset before 3 months of age had a remission,
whereas 78% (seven of nine) with onset after 3 months had a
remission. The lack of relationship between pathologic lesions
(such as microcystic tubules), and outcome is emphasized by
the fact that the single patient with congenital nephrotic syn-
drome defined here as onset less than 3 months of age who
recovered had typical "Finnish" microcystic tubular lesions as
did three of four infants with onset at 5 to 7 months of age who
recovered (Table 3). In this study microcystic tubular changes
were present in 67% of 39 patients with congenital nephrotic
syndrome, a frequency similar to that reported in various
studies of this syndrome in Finland [8, 91.
This study affirms the complexity of the glomerular and
tubular abnormalities which can be encountered in infants with
nephrotic syndrome in the first year of life. Prior attempts at
classification have recognized several pathologic lesions:
microcystic tubules, mesangial proliferation, focal segmental
glomerular sclerosis and global glomerular sclerosis, and have
often considered the presence of microcystic tubules in associa-
tion with any of the other lesions, as indicative of the "Finnish"
type of congenital nephrotic syndrome, and of a grave progno-
sis [3, 5, 7, 9, 12, 13, 16, 19]. In the absence of microcystic
tubules, the disease has traditionally been classified on the basis
of the most prominent glomerular lesion or, in the absence of a
lesion, as minimal change nephrotic syndrome [5, 7, 9]. We feel
this simplistic classification should be abandoned. The fact that
25% of Finnish infants with congenital nephrotic syndrome do
not have microcystic tubules but are identical with patients with
microcysts in all other aspects [8], further emphasizes the
futility of this classification system. The lack of specificity of
the microcystic tubule is also emphasized by our observation
(Table 6) that only one of each of five pairs of affected siblings
had this "classic" lesion of "Finnish microcystic disease."
What then is the pathologic significance of microcystic tu-
bules? We speculate that this lesion may be acquired as a
consequence of the nephrotic state (proteinuria), occurring in
the immature kidney. Further studies, including experimental
forms of nephrotic syndrome in newborn animals are required
to substantiate this hypothesis.
No other pathologic lesion present in either initial tissue
specimens obtained early in the course of the disease(s), or in
specimens obtained at later times, occurred with a statistically
different frequency in infants with congenital nephrotic syn-
drome, as compared with those infants with onset between 5
and 12 months of age. Microglomeruli were more frequent in
early specimens than in late samples, but focal segmental
glomerular sclerosis and hyalinosis was more frequent in later
specimens, regardless of the age at onset; these lesions were not
useful predictors of eventual outcome. Analysis of the inci-
dence of various pathologic lesions in patients with positive or
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Table 8. Literature review: age at presentation and outcome of congenital and infantile nephrotic syndromea
Author [reference] Diagnosis
Age <3 months
# patients
Remission
no.
Age >3 months
# patients
Remission
no.
Alexander et al [11
Anand et al [2]
Bouton and Coulter [31
Fetterman and Feldman [4]
George et a! [5]
Giles et al [61
Habib and Bois [7]
Huttenen [9]
Kaplan et al [11]
Kjessler et a! [12]
Kristal and Lichtig [131
Lange et a! [141
McDonald et al [15]
Parker et al [16]
Schneller et a! [17]
Present series
MCD
MCD
MCD
MCD
MCD
MCD
MCD
MCD
MCD
MCD
MCD
MCD
MCD
MCD
MCD
MCD
3
1
5
1
6
3
10
75
2
2
4
2
1
4
2
22
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
1
1
1
4
0
0
1
0
3
Subtotal 143 2 8 4 P < 0.0001
Alexander et a! [1]
Habib and Bois [71
Kaplan eta! [11]
Kristal and Lichtig [13]
Schneller et a! [171
Present series
MCNS
MCNS
MCNS
MCNS
MCNS
MCNS
1
3
1
1
0
1
0
0
7
1
2
1
7
1
0
1
Subtotal 6 1 11 9 P < 0.01
Bouton and Coulter [3]
Habib and Bois [7]
Davin et a! [21]
Present series
FSGS/H
FSGS/H
FSGS/H
FSGS/H
2
2
1
7
0
1
1
0
5
2
3
2
Subtotal 12 2 7 5 P < 0.019
George et al [51
Mahieu et a! [33]
Schneller et al [17]
Present series
MesPGN
MesPGN
MesPGN
MesPGN
1
3
3
10
1
0
0
0
5
1
3
1
Subtotal 16 1 6 4 P < 0.01
Total 177 6 32 22 P < 0.0001
Abbreviations: MCD, microcystic disease; MCNS, minima! change nephrotic syndrome; MesPGN, mesangial proliferative glomerulonephntis;
FSGSIH, focal segmental glomerulosclerosis/hyalinosis.
a P values were determined by the Fisher exact test; the P value compares age less than and greater than 3 months in each histologic diagnostic
category.
Immunofluorescent microscopy performed in patients from
both age groups was positive for mesangial IgG, 1gM, and C3 in
about 50% of specimens. These antigens were distributed
primarily in the mesangial areas in glomeruli undergoing scle-
rosis and did not provide useful information regarding prognosis
or mechanisms of injury in the patients. The lack of specificity
of 1gM and C3 fluoresence in sclerotic glomeruli in other
diseases has been emphasized recently [31]. No instance of
granular capillary ioop oriented immune deposits were recog-
glomerular basement membranes, furthermore, did not dif-
ferentiate between good and poor prognostic groups, for the
basement membranes were thin but normal for age [30] in all
groups of patients, which is similar to the findings of Autio-
Harmainen and Rapola [32].
When we analyzed our patients with those from other re-
ports, we found that 171 of 177 (97%) patients with congenital
nephrotic syndrome died or required endstage renal care while
only 22 of 32 (3 1%) patients with onset after 3 months suffered
the same fate (P < 0.0001, Table 8). It should be noted that
many infants presenting before age 3 months, but all of whom
died or had a poor outcome, are excluded in this review for we
could not adequately classify some patients on the basis of the
histologic discriptions or illustrations. These figures also ex-
clude infants with diffuse mesangial sclerosis, which is associ-
negative family histories also demonstrated the inability of any nized in this series. Our ultrastructural measurements of
lesion to discriminate between patients who eventually
achieved remission and those who did not. Diffuse mesangial
sclerosis was associated with renal failure and death in the one
patient with this lesion in this series who had a similar poor
prognosis as in previously described cases and appears to be a
valuable predictor of lethal outcome [7, 11, 13, 17—20].
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ated with a poor outcome with both congenital (seven of seven)
[7, 11, 13, 17, 19] and infantile (12 of 12) onset [7, 13, 18, 20].
The frequency of remission in previously reported patients with
infantile nephrotic syndrome is similar to that of the present
series (Table 8). This analysis further supports the view that age
of onset rather than renal pathology other than diffuse mesan-
gial sclerosis is the most important predictor of eventual out-
come of the nephrotic syndrome occuring in infants.
The clinical features, natural history, management, and re-
suits of renal transplantation in the 39 patients with congenital
nephrotic syndrome whose pathology is described here are
reported elsewhere [281. We found that there were no clinical
characteristics, including signs or symptoms at presentation,
laboratory data, nationality, or family history, which predicted
or correlated with any of the histologic subtypes described in
this report. The onset of nephrotic syndrome within the first
three months of life has an almost uniformly poor prognosis,
unless intensive supportive care permits growth and the poten-
tial for survival via renal transplantation or dialysis. Intensive
support also appears to be indicated as the only measure which
may allow recognition of the rare patient with congenital
nephrotic syndrome who may achieve spontaneous remission.
Acknowledgments
Portions of this paper were presented at the Annual Meeting of the
Pediatric Pathology Club, Atlanta, Georgia, February 26, 1983. The
authors thank M. Carlson, J. Judge, M. Berry, and S. Johnson for
technical assistance and B. Logas for secretarial assistance.
Reprint requests to Dr. R. K. Sibley, Department of Laboratory
Medicine and Pathology, Box 609, Mayo Memorial Building, Uni-
versity of Minnesota, 420 Delaware Street, SE, Minneapolis, Min-
nesota 55455, USA
References
1. ALEXANDER F, CAMPBELL WAB: Congenital nephrotic syndrome
and renal vein thrombosis in infancy. J Gun Pathol 24:27-40, 1971
2. ANAND SK, NORTHWAY JD, VERNIER RC: Congenital nephrotic
syndrome: report of a case with cystic tubular changes who
recovered. J Pediatr 95:265—268, 1979
3. BOUTON JM, COULTER JBS: The nephrotic syndrome of infancy.
Acta Paediatr Scand 63:769—776, 1974
4. FETTERMAN GH, FELDMAN JD: Congenital anomalies of renal
tubules in a case of "infantile nephrosis." Am J Dis Child
100:319—331, 1960
5. GEORGE CRP, HICKMAN RO, STRIKER GE: Infantile nephrotic
syndrome. Cliii Nephrol 5:20—24, 1976
6. GILES HM, PUGH RCB, DARMADY EM, STRANACK F, WOOLF LI:
The nephrotic syndrome in early infancy: A report of three cases.
Arch Dis Child 32:167—180, 1957
7. HABIB R, BoIs E: Congenital and infantile nephrotic syndrome, in
Pediatric Nephrology, edited by STRAUSS J, New York, Stratton
Intercontinental Medical Book Corporation, 1976, vol 1, pp
335—349
8. HALLMAN N, NORIO R, RAPOLA J: Congenital nephrotic syndrome.
Nephron 11:101—110, 1973
9. HUTTUNEN N-P: Congenital nephrotic syndrome of Finnish type.
Study of 75 patients. Arch Dis Child 51:344—348, 1976
10. HOYER JR, MICHAEL AF, GOOD RA, VERNIER RL: The nephrotic
syndrome of infancy: clinical, morphologic and immunologic stud-
ies of four infants. Pediatrics 40:233—245, 1967
11. KAPLAN BS, BUREAU MA, DRUMMOND KN: The nephrotic syn-
drome in the first year of life: Is a pathologic classification possible?
JPediatr 85:615—621, 1974
12. KJESSLER B, HULTQUIST G, JOHANSSON SGO, SHERMAN MS.
GU5TAVSON KH: Antenatal diagnosis of congenital nephrosis of the
Finnish type. Acta Obstet Gynecol Scand 69(Suppl):59—77, 1977
13. KRISTAL H, LICHTIG C: Infantile nephrotic syndrome. Clinico-
pathological study of 11 cases. Isr J Med Sci 19:626—630, 1983
14. LANGE K, WACHSTEIN M, WASSERMAN E, ALPTEKIN F, SLOBODY
LB: The congenital nephrotic syndrome: An immune reaction? Am
J Dis Child 15:338—345, 1963
15. MCDONALD R, WIGGELINKHUIZEN J, KASCHULA ROC: The ne-
phrotic syndrome in very young infants. Am J Dis Child
122:507—512, 1971
16. PARKER RA, PIEL CF: The nephrotic syndrome in the first year of
life. Pediatrics 22:967—976, 1960
17. SCHNELLER M, BRAGA SE, MOSER H, ZIMMERMANN A, OETLIKER
0: Congenital nephrotic syndrome: Clinicopathological hetero-
geneity and prenatal diagnosis. Clin Nephrol 19:243—249, 1983
18. MENDELSOHN HB, KRAUSS M, BERANT M, LICHTIG C: Familial
early-onset nephrotic syndrome: Diffuse mesangial sclerosis.
Clinicopathological study of a kindred. Acta Paediatr Scand
71:753—758, 1982
19. RUMPELT HJ, BACHMAN HJ: Infantile nephrotic syndrome with
diffuse mesangial sclerosis: A disturbance of glomerular basement
membrane development? Clin Nephrol 13:146-150, 1980
20. SEELIG HP, SEELIG R, SCHARER K: Immunohistologische Ut-
tersuchungen bei der diffusen mesangialen Sklerose mit
nephrotischem Syndrom in Sauglingsalter. Z Kinderheilk
120:111—120, 1975
21. DAVIN JC, DECHENNE C, CHANTRAINE JM: A case of congenital
nephrotic syndrome. Nephron 28:32—35, 1981
22. ZUNIN C, SOAVE F: Association of nephrotic syndrome and
nephroblastoma in siblings. Ann Paediatr 203:29—38, 1964
23. SIMILA S, VESA L, WASZ-HOCKERT 0: Heriditary onycho-
osteodysplasis (nail-patella syndrome) with nephrosis like renal
disease in a new born baby. Pediatrics 46:61—65, 1970
24. GOTLOIB L, LONDON R, ROSENMANN E: Infantile nephrotic syn-
drome due to glomerulonephritis in a male pseudohermaphrodite.
Isr J Med Sci 12:52—58, 1976
25. GENTNER JM, KAUSCHOWSKY A, GRESHER DW, SIEGEL NJ, BREG
WR, GENEL M: XY gonadal dysgenesis associated with the con-
genital nephrotic syndrome. Obstet Gynecol 35:665—695, 1980
26. WORTHEN HG, VERNIER RL, GOOD RA: Infantile nephrosis.
Clinical, biochemical and morphologic studies of the syndrome. Am
J Dis Child 98:731—748, 1959
27. SHAHIN B, PAPADOPOULOW ZL, JENI5 EH: Congenital nephrotic
syndrome associated with congenital toxoplasmosis. Pediatrics
85:366—370, 1974
28. MAHAN JD, MAUER SM, SIBLEY RK, VERNIER RC: Congenital
nephrotic syndrome: The evolution of medical management and
results of renal transplantation. J Pediatr 105:548—557, 1984
29. KIM Y, VERNIER RL, FISH AJ, MICHAEL AF: Immunofluorescence
studies of dense deposit disease. The presence of railroad tracks
and mesangial rings. Lab invest 110:474—480, 1979
30. VERNIER RL: Electron microscopic studies of normal basement
membranes, in Small Blood Vessel involvement in Diabetes Mel-
litus, edited by SIPERSTEIN MD, COLWELL AR, MEYERS K,
Washington, D.C., American Institute of Biological Sciences, 1964,
p 57
31. YANG J-Y, MELVIN T, SIBLEY R, MICHAEL AF: No evidence for a
specific role of 1gM in mesangial proliferation of idiopathic ne-
phrotic syndrome. Kidney mt 25:100—106, 1984
32. AUTIO-HARMAINEN H, RAPOLA J: The thickness of the glomerular
basement membrane in congenital nephrotic syndrome of the
Finnish type. Nephron 34:48—50, 1983
33. MAHIEU P, MONNENS L, VAN HAELST U: Chemical properties of
glomerular basement membrane in congenital nephrotic syndrome.
Clin Nephrol 5:134—139, 1976
